Skip to content

Clinical trials

Phase 1 Arthritis, Rheumatoid trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 1 Country / region: Australia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20141
20161
20172
20211
20222
20255
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
GlaxoSmithKline2
Kali Therapeutics, Inc.2
Bristol-Myers Squibb1
Candid Therapeutics1
Capstan Therapeutics1
Eli Lilly and Company1
Hutchison Medipharma Limited1
Innocare Pharma Australia Pty Ltd1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid22
Lupus Erythematosus, Systemic8
Autoimmune Diseases3
Scleroderma, Systemic3
Myositis2
Sjogren's Syndrome2
Arthritis, Psoriatic1
Connective Tissue Diseases1
Dermatitis, Atopic1
Dermatomyositis1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.